NASDAQ: IRD
Opus Genetics Inc Stock Ownership - Who owns Opus Genetics?

Insider buying vs selling

Have Opus Genetics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Foundation Fighting Blindness Retinal Degeneration FundDirector2026-09-30556,000$4.96
$2.76MSell
George MagrathCEO2026-09-0975,541$5.97
$450.98kSell
George MagrathCEO2026-09-09392,157$1.15
$450.98kBuy
Cam GallagherDirector2026-09-08784,314$1.15
$901.96kBuy
Robert E. GagnonCFO2026-09-0328,000$4.54
$127.20kSell
Robert E. GagnonCFO2026-07-237,783$2.95
$22.94kSell
Benjamin R. YerxaPres2026-07-237,429$2.97
$22.06kSell
Joseph K. SchachleCOO2026-07-234,644$2.94
$13.65kSell
George MagrathCEO2026-07-239,475$2.95
$27.92kSell
Foundation Fighting Blindness Retinal Degeneration FundDirector2026-05-181,700,000$4.35
$7.39MSell

1 of 3

IRD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IRD insiders and whales buy or sell their stock.

IRD Shareholders

What type of owners hold Opus Genetics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Sungkee Chung196.88%163,800,000$750.20MInsider
Sung Sook Park84.38%70,200,000$321.52MInsider
Frank Ferraro31.25%26,000,000$119.08MInsider
Inok Ahn16.83%14,000,000$64.12MInsider
Chang Ho Ahn13.83%11,510,000$52.72MInsider
Rexgene Biotech Co Ltd6.62%5,505,956$25.22MInsider
Foundation Fighting Blindness Retinal Degeneration Fund3.89%3,236,171$14.82MInsider
Cam Gallagher3.57%2,966,111$13.58MInsider
Young Soon Park3.25%2,706,500$12.40MInsider
George Magrath2.46%2,048,485$9.38MInsider

1 of 3

IRD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IRD0.02%99.98%Net SellingNet Buying
SDEV0.00%100.00%Net Buying
RLMD0.09%3.69%Net BuyingNet Buying
ENTA0.09%48.86%Net SellingNet Selling
KYTX0.06%42.88%Net Buying

Opus Genetics Stock Ownership FAQ

Who owns Opus Genetics?

Opus Genetics (NASDAQ: IRD) is owned by 0.07% institutional shareholders, 371.19% Opus Genetics insiders, and 0.00% retail investors. Sungkee Chung is the largest individual Opus Genetics shareholder, owning 163.80M shares representing 196.88% of the company. Sungkee Chung's Opus Genetics shares are currently valued at $750.20M.

If you're new to stock investing, here's how to buy Opus Genetics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.